DOXIMITY INC DL-,001 Logo
US26622P1075
A3CS1K
DOCS

DOXIMITY INC DL-,001

Kurser indlæses...

Prognose

Analytikernes gennemsnitlige kursmål er 28,93 € (+7,15 %). Medianen er 29,62 € (+9,70 %).

Køb
  9
Behold
  13
Sælg
  2

Diskussioner i communityet

Der er endnu ingen diskussion om dette aktiv.

Start diskussion

  • Doximity falls after downgrade by Freedom Capital

    Doximity shares dropped 5.6% after Freedom Capital cut its rating from "buy" to "hold" while raising the price target from $24 to $27. The company reported Q1 results above expectations and raised its revenue outlook but lowered its EBITDA forecast to fund increased investments in AI development and computing power. Freedom Capital reduced its mid-point EBITDA estimate for 2027 from $329 million to $319 million and cited a balanced risk-reward profile for the downgrade; competition from Epic and OpenEvidence and tight pharma budgets remain risks, while AI search contracts are showing early positive momentum. » Mere på de.investing.com


  • Doximity CEO sells 8,505 shares to cover tax withholding after equity vesting

    Doximity CEO Jeffrey Tangney sold 8,505 Class A shares on August 15 to satisfy tax withholding from vested awards, a non-discretionary transaction that reduced his direct stake by roughly 0.3% to 2,531,955 shares (about 1% ownership). The sale does not reflect a market judgment by Tangney and three other insiders had similar withholdings the same day. Company results show slowing top-line growth, margin pressure from rising AI compute costs, and a guidance lull as AI-related revenue recognition is expected later in the year, while the stock has fallen over 60% in the past year. » Mere på finance.yahoo.com


  • Doximity granted president 150,000 options as he sold small stake to cover taxes

    Doximity president Steven L. Zatz sold 4,482 Class A shares in a non‑discretionary sell‑to‑cover to satisfy tax withholding after RSU vesting and retains 51,864 shares (~$1.29m at $24.80). The company granted Zatz 150,000 options on July 22 with a $20.49 strike that begin vesting in July 2027, tying future pay to stock appreciation. Doximity reported Q2 revenue of $156.6m (7% growth) and raised its full‑year range while AI compute costs lowered gross margin to 87.5% and adjusted EBITDA fell 6% to $74.8m; management says higher‑than‑expected AI usage should drive future revenue recognition. Investors should note the option grant links executive upside to stock performance as AI‑related costs and upcoming AI revenue recognition will affect margins and earnings. » Mere på finance.yahoo.com


  • Doximity CFO sells shares to cover taxes but keeps $12.1 million stake

    Doximity CFO Matthew Sonefeldt reported a non-discretionary sale of 15,311 Class A shares on August 15 to satisfy tax obligations from equity vesting, leaving him with 486,238 shares valued at about $12.1 million. The filing does not signal a change in his view of the company. Doximity posted TTM revenue of $655.6 million and net income of $167.0 million, but guided to roughly 1% revenue growth for the September quarter as AI-related timing and higher AI compute costs pressured gross margin and adjusted EBITDA; the company also spent $91.6 million on share repurchases. Investors should note the transaction was routine vesting-related withholding and weigh it against the company's mixed near-term growth outlook and solid profitability. » Mere på finance.yahoo.com


  • Doximity says AI is generating high‑margin searches, shares jump

    Doximity reported fiscal Q1 revenue of $156.6 million, up 7% year‑over‑year, while adjusted EBITDA fell 6% to $74.8 million as the company invests in AI. Management said its AI assistant outperformed peer models in an independent study, driving AI prompt volume up more than 25% quarter‑on‑quarter and AI Scribe users rising tenfold in July. CEO Jeff Tangney stated the company earns more than 10 times the cost per AI search today and expects AI costs to decline over time, signaling strong profit potential and prompting the stock rally. » Mere på finance.yahoo.com

I 2022 har DOXIMITY INC DL-,001 allerede udloddet 0,54 € i udbytte. Den seneste udlodning fandt sted i juli 2022.

Virksomhedstal

I det seneste kvartal havde DOXIMITY INC DL-,001 en omsætning på 154,09 mio. € og et nettoresultat på 30,66 mio. €
(EUR) september 2026
YoY
Omsætning 154,09 mio. 7,30 %
Bruttofortjeneste 131,71 mio. 1,62 %
Nettoresultat 30,66 mio. 42,02 %
EBITDA 48,27 mio. 25,86 %

Fundamentale data

Nøgletal Værdi
Markedsværdi
5,05 mia. €
Antal aktier
178,24 mio.
Højeste/laveste i 52 uger
47,25 € - 15,63 €
Udbytte Nej
Beta
1,29
P/E (PE Ratio)
41,48
PEG (PEG Ratio)
-0,94
K/I (PB Ratio)
5,99
P/S (PS Ratio)
8,38

Virksomhedsprofil

Doximity, Inc. driver en cloudbaseret digital platform for læger og andre medicinske fagfolk i USA. Virksomhedens platform giver sine medlemmer værktøjer, der er udviklet til medicinske fagfolk, og gør det muligt for dem at samarbejde med kolleger, koordinere patientbehandling, gennemføre virtuelle patientkonsultationer, holde sig opdateret med de seneste medicinske nyheder og forskning samt styre deres karriere. Platformen henvender sig primært til farmaceutiske producenter og sundhedssystemer. Virksomheden var tidligere kendt som 3MD Communications, Inc. og skiftede navn til Doximity, Inc. i juni 2010. Doximity, Inc. blev stiftet i 2010 og har hovedkontor i San Francisco, Californien.

Navn
DOXIMITY INC DL-,001
CEO
Jeffrey A. Tangney
Hjemsted San Francisco, ca
USA
Websted
Sektor
Sundhed
Branche
Sundhedsteknologi
Børsnotering
02.01.2008
Medarbejdere 880

Tickersymboler

Børs Symbol
NYSE
DOCS
🍪

Parqet  bruger cookies. Læs mere